CRISPR-Cas9 has been the most widely used technology for gene editing and has been applied in clinical trials for genetic disorders.

Gaganyaan is India's first crewed spaceflight mission, aiming to send Indian astronauts into space.

Aditya-L1 is India's first dedicated solar observatory mission, aimed at studying the Sun's outer layers.

In 2022, Moderna announced progress on a universal flu vaccine using its mRNA technology, aiming to provide broader protection against various flu strains.

In 2022, researchers made significant advancements in natural language processing, particularly in contextual understanding, allowing AI to better grasp the nuances of human language.

In 2021, researchers reported advancements in CRISPR-Cas13, which is used for RNA editing, allowing for potential treatments of various diseases.

In 2022, lab-grown meat received FDA approval for human consumption, marking a significant advancement in the biotech industry.

Google added Augmented Reality Navigation to Google Maps, allowing users to see directions overlaid on the real world through their camera.

In 2023, AI chatbots were enhanced with emotional intelligence, allowing them to better understand and respond to user emotions.

Attention Mechanisms were further refined in 2022, allowing AI models to better understand context in language processing.

The SSLV-D1 marked ISRO's first launch of a Small Satellite Launch Vehicle, designed for quick deployment of small satellites.

In 2021, the first human trial using CRISPR technology for the treatment of sickle cell disease was successfully initiated.

NavIC is a satellite-based navigation system developed by ISRO to provide accurate positioning services.

The SSLV uses solid propulsion technology, designed for quick deployment of small satellites.

In 2021, researchers reported the creation of a fully synthetic organism, marking a significant milestone in synthetic biology.

In 2022, a major focus of AI research was on bias mitigation to ensure fair and equitable AI systems.

The collaboration focused on synthetic biology applications for biosecurity, aiming to enhance the U.S. defense against biological threats.

The 2023 research breakthrough focused on using CRISPR technology to target specific cancer cells, enhancing precision in cancer treatment.

In 2023, researchers made significant advancements in synthetic biology by engineering bacteria for targeted drug delivery systems.

Mangalyaan-2 is designed to conduct detailed atmospheric studies of Mars, building on the success of the first mission.

IBM developed an AI model in 2023 aimed at developing personalized treatment plans for patients, leveraging data to tailor healthcare solutions.

Aditya-L1 is designed to study solar activities and their impact on the Earth's climate.

PSLV-C52 was primarily aimed at launching the communication satellite EOS-04 into orbit.

RISAT-1 was launched for Earth observation, providing all-weather surveillance and reconnaissance capabilities.

In 2023, Google and DeepMind focused their AI research collaboration on enhancing protein folding predictions, which is crucial for understanding diseases.

The collaboration aimed at creating monoclonal antibodies to treat COVID-19, enhancing the therapeutic options available during the pandemic.

Chandrayaan-2 aimed to land on the Moon's surface and explore its south pole region.

Chandrayaan-3 aimed to achieve a soft landing on the Moon's south pole, following the partial success of Chandrayaan-2.

Chandrayaan-3 aimed to achieve a soft landing on the Moon's south pole, following the partial success of Chandrayaan-2.

The Gaganyaan mission aims to send Indian astronauts to space, marking India's first human spaceflight program.